Group of action: Agents affecting the digestive system and metabolism

Active ingredient: Ranitidine hydrochloride

Dosage form: Film-coated tablets

Pharmacotherapeutic group: Agents for treatment of peptic ulcer and gastroesophageal reflux disease. H2 receptor antagonists. Ranitidine.

ATC code: A02BA02

RX/OTC: RX

 

Indications  

Peptic ulcer and duodenal ulcers, not associated with Helicobacter pylori (in exacerbation phase), including ulcers associated with nonsteroidal anti-inflammatory drugs (NSAIDs);

  • functional dyspepsia;
  • chronic gastritis with increased acid-forming function of the stomach in exacerbation phase;
  • gastroesophageal reflux disease (to relieve symptoms) abo reflux esophagitis.
Contraindications   Individual hypersensitivity to the drug; the presence of malignant diseases of the stomach, liver cirrhosis with portosystemic encephalopathy in anamnesis; severe renal insufficiency.
Basic physical and chemical properties   Film-coated tablets from light orange to orange in color, with a biconvex surface. At the break is seen under a magnifying glass core surrounded by a continuous layer.
Shelf life   3 years
Storage conditions   Keep out of reach of children in the original packaging at a temperature not exceeding 25 ° C.